Long Intergenic Non-Protein Coding RNA 00342 Exerts Oncogenic Effects in Prostate Cancer by Sponging microRNA-19b-3p and Thereby Increasing Forkhead Box F2 Expression

Author:

Li Qingyuan1,Zhong Jingjie1,Zhang Jandong1,Zhang Hao1,Li Feng2

Affiliation:

1. Department of Urology, Yantai Harbour Hospital, Yantai, Shandong, 264013, China

2. College of Pharmacy of Binzhou Medical University, Yantai, Shandong, 264003, China

Abstract

Prostate cancer is one of the most common malignancies in males with increasing morbidity and mortality. Related reports indicate that lncRNAs may be a new class of potential tumor molecular markers. Compared with the normal tissues, the expression level of LINC00342 in prostate cancer tissues was significantly increased. Compared with normal PC3 and DU145 cells, cells silenced by the LINC00342 gene significantly decreased the ability of proliferation, migration, invasion, and induced apoptosis. Further, the FISH assay showed that LINC00342 could interact with miR-19b-3p and control the expression of Forkhead Box F2 (FOXF2), the target of miR-19b-3p. LINC00342 could activate the ERK/AKT signaling pathways. Tumor xenograft formation assay demonstrated that the down-regulated LINC00342 prevented tumor formation in vivo. Taken together, these results indicated that the interference of LINC00342 expression might inhibit the invasion, migration and promote apoptosis of prostate cancer cells by inhibiting the ERK1/2/AKT signaling pathway via sponging miRNA-19b-3p and thereby increasing FOXF2 expression.

Publisher

American Scientific Publishers

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Reference21 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA-A Cancer Journal for Clinicians,2018

2. Cancer incidence and mortality: A cohort study in China, 2008–2013;Pan;International Journal of Cancer,2017

3. Early diagnostic role of PSA combined miR-155 detection in prostate cancer;Guo;European Review for Medical and Pharmacological Sciences,2018

4. Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets;Chandra;International Journal of Cancer,2017

5. Noncoding RNAs in prostate cancer: The long and the short of it;Bolton;Clinical Cancer Research,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3